Rosuvastatin Calcium Tablet
Product Images NDC 68788-4047

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68788-4047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rosuvastatin Calcium Tablets 20mg (Rosuvastatin Tablets 20mg 90s Bottle Label)

Rosuvastatin Calcium Tablets 20mg (Rosuvastatin Tablets 20mg 90s Bottle Label)
Label for Rosuvastatin Calcium Tablets 20 mg, a generic for Crestor, showing a film-coated tablet dosage form. The label includes manufacturer info for Umedica Laboratories Pvt. Ltd., storage instructions, and barcodes. Directions for use are presented in English and Spanish, with space for filling in the number of tablets and daily frequency.*
FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
A line graph showing cumulative incidence percentage over 6 years comparing Rosuvastatin (solid line) and Placebo (dotted line). The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and p-value (<0.001). Below the graph is a table showing the number of patients at risk over time for RSV (Rosuvastatin) and Placebo groups.*
FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
A data table comparing the number of events for Rosuvastatin Calcium 20 mg versus placebo 20 mg, including endpoints like primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization, presented with hazard ratios (HR), 95% confidence intervals, and p-values, alongside a hazard ratio forest plot.*
FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
A box plot chart comparing the percent change from baseline in LDL-C levels across different doses of four statin drugs: Crestor (rosuvastatin), Atorvastatin, Simvastatin, and Pravastatin. The horizontal axis shows dosages in milligrams for each drug, while the vertical axis depicts percent LDL-C reduction ranging from 0% to -75%.*
FDA Label Image
FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Structural_formula (Rosuvastatin Tablets Structure)
Chemical structure of Rosuvastatin Calcium, showing its molecular components including the fluorophenyl group, sulfonamide moiety, and calcium ion with a charge of 2+. The structure represents two Rosuvastatin molecules complexed with one calcium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.